Anktiva
Anktiva ingredients
| Active ingredient | Strength |
|---|---|
| Nogapendekin Alfa Inbakicept-Pmln | 400 ug/.4mL |
What Anktiva is used for
Anktiva is a specialist medicine (interleukin-15 receptor agonist). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Anktiva
- Generic name
- Nogapendekin alfa inbakicept-pmln
- Made by
- Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc.
- Forms
- Solution
- Given
- Intravesical
- Drug class
- Interleukin-15 Receptor Agonist
- FDA approval
- Biologic licence (BLA) BLA761336
- On the US market since
- 2024
Official information
- MedlinePlus drug information (search for Nogapendekin alfa inbakicept-pmln)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Anktiva?
Anktiva (Nogapendekin alfa inbakicept-pmln) is a specialist medicine made by Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc., approved by the US FDA.
What are the ingredients of Anktiva?
Anktiva contains Nogapendekin Alfa Inbakicept-Pmln (400 ug/.4mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA